Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 1, 2006, Pages 52-57

  Di Nisio, Marcello ^a,b,c   Rutjes, A W S ^b   Buller H R ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NONE   (Netherlands)

Author keywords

Cancer; D dimer test; Deep venous thrombosis; Pretest clinical probability

Indexed keywords

D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ARTICLE; CANCER; CANCER PATIENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOEMBOLISM; BLOOD; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PREDICTION AND FORECASTING; VEIN THROMBOSIS;

AGED; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROBABILITY; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS;

EID: 33644863717     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01671.x     Document Type: Article

References (21)

1. Lee AYY. Management of thrombosis in cancer: Primary prevention and secondary prophylaxis. Br J Haematol 2004; 128: 291-302.
2. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293: 715-22.
3. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. New Engl J Med 2000; 343: 1846-50.
4. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest 2004; 126: S401-28.
5. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis. J Clin Oncol 2000; 18: 3078-83.
6. Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-8.
7. Elting LS, Escalante CP, Cooksley C, Avritscher EBC, Kurtin D, Hamblin L, Khosla SG, Rivera E. Outcomes and costs of deep venous thrombosis among patients with cancer. Arch Intern Med 2004; 164: 1653-61.
8. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-74.
9. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, Biel RK, Bharadia V, Kalra NK. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism. Ann Intern Med 2004; 140: 589-602.
10. Kelly J, Rudd A, Lewis RR, Hunt BJ. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med 2002; 162: 747-56.
11. ten Wolde M, Kraaijenhagen RA, Prins MH, Buller HR. The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. Arch Intern Med 2002; 162: 1880-4.
12. Lee AYY, Julian JA, Levine MN, Weitz JI, Kearon C, Wells PS, Ginsberg JS. Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis. Ann Intern Med 1999; 131: 417-23.
13. Bates SM, Grand'Maison A, Johnston M, Naguit I, Kovacs MJ, Ginsberg JS. A latex D-dimer reliably excludes venous thromboembolism. Arch Intern Med 2001; 161: 447-53.
14. Lennox AF, Delis KT, Serunkuma S, Zarka ZA, Daskalopoulou SE, Nicolaides AN. Combination of a clinical risk assessment score and rapid whole blood D-dimer testing in the diagnosis of deep vein thrombosis in symptomatic patients. J Vasc Surg 1999; 30: 794-804.
15. Bates SM, Kearon C, Crowther M, Linkins L, O'Donnell M, Douketis J, Lee AYY, Weitz JI, Johnston M, Ginsberg JS. A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosis. Ann Intern Med 2003; 138: 787-94.
16. Shitrit D, Levi H, Huerta M, Rudensky B, Bargil-Shitrit A, Gutterer N. Appropriate indications for venous duplex scanning based on D-dimer assay. Ann Vasc Surg 2002; 16: 304-8.
17. Schutgens REG, Esseboom EU, Haas FJLM, Nieuwenhuis HK, Biesma DH. Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients. Am J Med 2002; 112: 617-21.
18. Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, Weitz JI, D'Ovidio R, Cogo A, Prandoni P, Girolami A, Ginsberg JS. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326-30.
19. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-35.
20. Tamariz LJ, Eng J, Segal JB, Krishnan JA, Bolger DT, Streiff MB, Jenckes MW, Bass EB. Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: A systematic review. Am J Med 2004; 117: 676-84.
21. Fancher TL, White RH, Kravitz RL. Combined use of a rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: Systematic review. BMJ 2004; 329: 821.